MaaT Pharma SA is involved in developing microbiome-based therapeutics. The company focuses on harnessing the gut microbiome to improve patient outcomes, particularly in cancer treatments and other health-related areas.
1923
France
51 - 200 employees
Biotechnology
$1M - 10M in revenue
Not profitable
Beyond Top 1000
Beyond Top 100
Beyond Top 100
Beyond Top 100
See all
Carbon emissions
Electricity consumption
Carbon certificate projects
Targets
Other sustainability metrics
Target | Year | Value | Scope | Baseline |
---|---|---|---|---|
Interim emissions reductionⓈCompany sustainability report | 2030 | 50% | 1&2&3 (value chain) | 2018 |
The initial carbon assessment is primarily focused on Scope 3 emissions, which amount to 1,958.19 TeCO2. The main contributors are subcontracting purchases, followed by goods purchases and transportation related to stool collection. MaaT Pharma is committed to evolving its carbon assessment by implementing indicators focused on production processes and sustainable supplier selection. However, specific quantitative progress towards a net zero target is not provided.
Category | Description | Metric | Year | ||
---|---|---|---|---|---|
Social | Share of female employees | % |
Sustainability employees
2-3
ⓈThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.Fake Job Title 1
**************
Fake Job Title 2
**************
Disclaimer: The information provided by illuminem ("we", "us") is for general informational purposes only. All information on the pages is provided in good faith, however we make no representation or warranty of any kind, express or implied, regarding the accuracy of any information on the pages. The information on the pages is either provided to us directly by the companies to which the information relates, or by third-party data providers, or derives from publicly available sources. In certain instances the information might be estimations based on limited information publicly available. Your reliance on any information provided on the pages is solely at your own risk. If you believe that any information is incorrect or in breach of your rights, please contact us.